Soluble Amyloid-&bgr; Levels and Late-Life Depression

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|15|2547-2554

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.15, 2014-05, pp. : 2547-2554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Antidepressants in Late-Life Depression

By Rajji Tarek K.   Mulsant Benoit H.   Lotrich Francis E.  

Drugs & Aging, Vol. 25, Iss. 10, 2008-01 ,pp. : 841-853

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and the serotonin transporter in late-life depression

By Gerretsen Philip   Pollock Bruce G  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 12, 2008-12 ,pp. : 1465-1478

Informa Healthcare

Access to resources Recommend Favorite

Treatment-resistant Late-life Depression: Challenges and Perspectives

By  

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 577-591

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Modeling, Virtual and In Vitro Screening for Acetylcholinesterase Inhibitors and their Effects on Amyloid-&bgr; Self- Assembly

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-03 ,pp. : 2-14

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Comparative Review

By Solai L.K.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 355-368

Adis International

Access to resources Recommend Favorite